Reviewed,
UniProtKB/Swiss-Prot Q9BZZ5 (API5_HUMAN)
Last modified
November 24, 2009.
Version 59.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Apoptosis inhibitor 5 Short name=API-5 Alternative name(s): Fibroblast growth factor 2-interacting factor Short name=FIF Protein XAGL Antiapoptosis clone 11 protein Short name=AAC-11 Cell migration-inducing gene 8 protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 510 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Antiapoptotic factor that may have a role in protein assembly. Negatively regulates ACIN1. By binding to ACIN1, it suppresses ACIN1 cleavage from CASP3 and ACIN1-mediated DNA fragmentation. Also known to efficiently suppress E2F1-induced apoptosis. Its depletion enhances the cytotoxic action of the chemotherapeutic drugs. Ref.9 Ref.13 Ref.16 |
| Subunit structure | |
| Subcellular location | Nucleus. Cytoplasm. Note: Mainly nuclear. Can also be cytoplasmic. Ref.3 Isoform 3: Cytoplasm. |
| Tissue specificity | Expressed in all tissues tested, including heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Highest levels in heart, pancreas and placenta. Highly expressed in several cancers. Preferentially expressed in squamous cell carcinoma versus adenocarcinoma in non-small cell lung cancer. Ref.9 Ref.16 Ref.3 Ref.10 Ref.14 |
| Domain | Two regions, an N-terminal (aa 96-107) and a C-terminal (aa 274-311) are required for binding FGF2. |
| Sequence similarities | Belongs to the API5 family. |
| Sequence caution | The sequence AAB86528.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence AAB86528.1 differs from that shown. Reason: Frameshift at several positions. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Apoptosis |
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | anti-apoptosis Ref.1 Ref.3 Ref.9 Inferred from mutant phenotype. Source: UniProtKB apoptosisInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | cytoplasm Ref.3 Non-traceable author statement. Source: UniProtKB spliceosomal complexInferred from sequence or structural similarity. Source: UniProtKB |
| Molecular function | fibroblast growth factor binding Ref.3 Inferred from physical interaction. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. | ||||||
| Isoform 1 (identifier: Q9BZZ5-1) Also known as: FIF-510; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9BZZ5-2) Also known as: FIF-504; The sequence of this isoform differs from the canonical sequence as follows: 498-510: GERFRLGTRNMRD → ERSLQGK | ||||||
| Isoform 3 (identifier: Q9BZZ5-3) Also known as: FIF C1; The sequence of this isoform differs from the canonical sequence as follows: 371-373: KDF → HES 374-510: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 4 (identifier: Q9BZZ5-4) The sequence of this isoform differs from the canonical sequence as follows: 371-373: KDF → HES 498-510: GERFRLGTRNMRD → ERSLQGK |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.8 | ||||||
| Chain | 2 – 510 | 509 | Apoptosis inhibitor 5 | PRO_0000064634 | |||||
Regions | |||||||||
| Domain | 370 – 391 | 22 | Leucine-zipper | ||||||
Sites | |||||||||
| Site | 2 | 1 | Not acetylated | ||||||
Amino acid modifications | |||||||||
| Modified residue | 28 | 1 | Phosphotyrosine | ||||||
| Modified residue | 251 | 1 | N6-acetyllysine Ref.17 | ||||||
| Modified residue | 464 | 1 | Phosphoserine Ref.11 Ref.12 | ||||||
Natural variations | |||||||||
| Alternative sequence | 371 – 373 | 3 | KDF → HES in isoform 3 and isoform 4. | VSP_013196 | |||||
| Alternative sequence | 374 – 510 | 137 | Missing in isoform 3. | VSP_013197 | |||||
| Alternative sequence | 498 – 510 | 13 | GERFR…RNMRD → ERSLQGK in isoform 2 and isoform 4. | VSP_013198 | |||||
| Natural variant | 276 | 1 | P → S | VAR_021519 | |||||
| Natural variant | 300 | 1 | M → V: dbSNP rs5743240. Ref.6 | VAR_021520 | |||||
| Natural variant | 493 | 1 | G → S: dbSNP rs2862934. Ref.6 | VAR_021521 | |||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal." Tewari M., Yu M., Ross B., Dean C., Giordano A., Rubin R. Cancer Res. 57:4063-4069(1997) [PubMed: 9307294] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4). |
| [2] | "Molecular cloning and fine mapping of API5L1, a novel human gene strongly related to an antiapoptotic gene." Gianfrancesco F., Esposito T., Ciccodicola A., D'Esposito M., Mazzarella R., D'Urso M., Forabosco A. Cytogenet. Cell Genet. 84:164-166(1999) [PubMed: 10393420] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [3] | "FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2." Van den Berghe L., Laurell H., Huez I., Zanibellato C., Prats H., Bugler B. Mol. Endocrinol. 14:1709-1724(2000) [PubMed: 11075807] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH FGF2. Tissue: Liver. |
| [4] | "Identification of a human cell migration gene." Kim J.W. Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [5] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [6] | NIEHS SNPs program Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS SER-276; VAL-300 AND SER-493. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Lymph. |
| [8] | Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-9; 26-36; 131-148; 161-169; 244-251 AND 427-436, CLEAVAGE OF INITIATOR METHIONINE, LACK OF N-TERMINAL ACETYLATION, MASS SPECTROMETRY. Tissue: Ovarian carcinoma. |
| [9] | "AAC-11 overexpression induces invasion and protects cervical cancer cells from apoptosis." Kim J.W., Cho H.S., Kim J.H., Hur S.Y., Kim T.E., Lee J.M., Kim I.K., Namkoong S.E. Lab. Invest. 80:587-594(2000) [PubMed: 10780674] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY. |
| [10] | "Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer." Sasaki H., Moriyama S., Yukiue H., Kobayashi Y., Nakashima Y., Kaji M., Fukai I., Kiriyama M., Yamakawa Y., Fujii Y. Lung Cancer 34:53-57(2001) [PubMed: 11557113] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [11] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464, MASS SPECTROMETRY. |
| [12] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464, MASS SPECTROMETRY. Tissue: Epithelium. |
| [13] | "Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo." Morris E.J., Michaud W.A., Ji J.Y., Moon N.S., Rocco J.W., Dyson N.J. PLoS Genet. 2:E196-E196(2006) [PubMed: 17112319] [Abstract] Cited for: FUNCTION. |
| [14] | "The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia." Krejci P., Pejchalova K., Rosenbloom B.E., Rosenfelt F.P., Tran E.L., Laurell H., Wilcox W.R. J. Leukoc. Biol. 82:1363-1364(2007) [PubMed: 17827341] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [15] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-28 AND SER-464, MASS SPECTROMETRY. |
| [16] | "The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentation." Rigou P., Piddubnyak V., Faye A., Rain J.-C., Michel L., Calvo F., Poyet J.-L. EMBO J. 28:1576-1588(2009) [PubMed: 19387494] [Abstract] Cited for: FUNCTION, INTERACTION WITH ACIN1, TISSUE SPECIFICITY. |
| [17] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-251, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| U83857 mRNA. Translation: AAB86528.1. Sequence problems. Y15906 mRNA. Translation: CAA75867.1. AF229253 mRNA. Translation: AAK00737.1. AF229254 mRNA. Translation: AAK00738.1. AY311389 mRNA. Translation: AAQ76714.1. BT007093 mRNA. Translation: AAP35756.1. AY265973 Genomic DNA. Translation: AAO89077.1. BC017709 mRNA. Translation: AAH17709.1. | |
| IPI | IPI00554742. IPI00555572. IPI00555743. IPI00855856. |
| RefSeq | NP_001136402.1. NP_001136403.1. NP_006586.1. |
| UniGene | Hs.435771 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9BZZ5. 1 interaction. |
| STRING | Q9BZZ5. |
PTM databases | |
| PhosphoSite | Q9BZZ5. |
Proteomic databases | |
| PRIDE | Q9BZZ5. |
Genome annotation databases | |
| Ensembl | ENST00000455725; ENSP00000399341; ENSG00000166181; Homo sapiens. [Genome view] |
| GeneID | 8539. |
| KEGG | hsa:8539. |
| UCSC | uc001mxf.1. human. uc001mxg.2. human. |
Organism-specific databases | |
| CTD | 8539. |
| GeneCards | GC11P043290. |
| H-InvDB | HIX0009571. |
| HGNC | HGNC:594. API5. |
| HPA | HPA026598. |
| MIM | 609774. gene. |
| PharmGKB | PA24881. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | Q9BZZ5. |
Gene expression databases | |
| ArrayExpress | Q9BZZ5. |
| Bgee | Q9BZZ5. |
| CleanEx | HS_API5. |
| Genevestigator | Q9BZZ5. |
Family and domain databases | |
| InterPro | IPR008383. API5. IPR016024. ARM-type_fold. [Graphical view] |
| PANTHER | PTHR12758:SF11. API5. 1 hit. |
| Pfam | PF05918. API5. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 31984. |
| SOURCE | Search... |
Entry information
| Entry name | API5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9BZZ5 Secondary accession number(s): O15441, Q9Y4J7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


